Search - tctmd.com

Displaying 921 - 940 of 999

Sort: Relevancy | Date

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

Thrombocytopenia Serves as Marker of Short- and Long-term Mortality after TAVR

March 13, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

March 13, 2014

News Daily News

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

March 06, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

March 06, 2014

News Daily News

Aortic Regurgitation Confirmed as Powerful Mortality Predictor after TAVR

March 05, 2014

News Daily News

La Regurgitación Aórtica se Confirma como un Potente Predictor de la Mortalidad tras TAVR

March 05, 2014

News Daily News

A-fib Common After Aortic Valve Replacement

January 30, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

January 16, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

January 01, 2014

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

November 16, 2013

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Case Presentation Introduction: A Low to Intermediate Risk Patient with Symptomatic Aortic Stenosis Who Doesn't Want Surgery

Presentation TCT 2013

Case Presentation Introduction: A Low to Intermediate Risk Patient with Symptomatic Aortic Stenosis Who Doesn't Want Surgery

Presenter: Michael Mullen

October 30, 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

TCT-110. Lower risk of severe acute kidney injury in transcatheter aortic valve replacement: intracardiac echocardiography lowers radiocontrast medium requirements

Presentation TCT 2013

TCT-110. Lower risk of severe acute kidney injury in transcatheter aortic valve replacement: intracardiac echocardiography lowers radiocontrast medium requirements

Presenter: Thomas Bartel

October 29, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.